Evidence map›Paper›PMID 38822376›Full record

ArticleJournal of nanobiotechnology2024

Oral administration of probiotic spore ghosts for efficient attenuation of radiation-induced intestinal injury.

Cuixia Zheng, Mengya Niu, Yueyue Kong, Xinxin Liu, Junxiu Li, Xunwei Gong, Xinyuan Ren, Chen Hong, Menghao Yin, Lei Wang

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Targeting gut microbiota and metabolites in cancer radiotherapy.Clinical and translational medicine · 2025
    Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cuixia ZhengTranslational medicine Center, Huaihe Hospital of Henan University, Kaifeng, 475000, China.
Mengya NiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Yueyue KongXinjiang Aksu First People's Hospital, Akesu, 843000, China.
Xinxin LiuSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Junxiu LiSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Xunwei GongSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Xinyuan RenSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Chen HongTranslational medicine Center, Huaihe Hospital of Henan University, Kaifeng, 475000, China.
Menghao YinSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China.
Lei WangSchool of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450001, China. wanglei1@zzu.edu.cn.

Funding

Central Plains science and technology innovation leading talent project 234200510005China Postdoctoral Science Foundation 2023M730971Henan Provincial Medical Science and Technology Public Relations Program Provincial-Ministerial Co-Construction Youth Project SBGJ202303041National Natural Science Foundation of China 82272847National Natural Science Foundation of China 82303529The Henan Province Fund for Cultivating Advantageous Disciplines 222301420012
6 · The paper itself

Abstract

Radiation-induced intestinal injury is the most common side effect during radiotherapy of abdominal or pelvic solid tumors, significantly impacting patients' quality of life and even resulting in poor prognosis. Until now, oral application of conventional formulations for intestinal radioprotection remains challenging with no preferred method available to mitigate radiation toxicity in small intestine. Our previous study revealed that nanomaterials derived from spore coat of probiotics exhibit superior anti-inflammatory effect and even prevent the progression of cancer. The aim of this work is to determine the radioprotective effect of spore coat (denoted as spore ghosts, SGs) from three clinically approved probiotics (B.coagulans, B.subtilis and B.licheniformis). All the three SGs exhibit outstanding reactive oxygen species (ROS) scavenging ability and excellent anti-inflammatory effect. Moreover, these SGs can reverse the balance of intestinal flora by inhibiting harmful bacteria and increasing the abundance of Lactobacillus. Consequently, administration of SGs significantly reduce radiation-induced intestinal injury by alleviating diarrhea, preventing X-ray induced apoptosis of small intestinal epithelial cells and promoting restoration of barrier integrity in a prophylactic study. Notably, SGs markedly improve weight gain and survival of mice received total abdominal X-ray radiation. This work may provide promising radioprotectants for efficiently attenuating radiation-induced gastrointestinal syndrome and promote the development of new intestinal predilection.

Indexed as

ProbioticsRadiation-Protective AgentsSpores, BacterialAdministration, OralAnimalsApoptosisGastrointestinal MicrobiomeHumansIntestinesIntestine, SmallMaleMiceRadiation InjuriesRadiation Injuries, ExperimentalReactive Oxygen SpeciesRadiation-Protective AgentsReactive Oxygen SpeciesIntestinal injuryOral administrationProbiotic spore ghostsRadioprotection

Identifiers

PMID38822376
PMCPMC11140926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.